Figure 6From: Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin ReceptorsTLR7 stimulation modulates p38 and JNK phosphorylation in CLL but has significantly less pronounced or no effect on stereotyped subset #4 cases. (A) Immunoblotting studies revealed that stimulation through TLR7 with imiquimod affects JNK and p38 phosphorylation in various CLL subgroups, both unmutated and mutated, with the significant exception of stereotyped subset #4 cases that are generally also nonresponsive to TLR7 stimulation in terms of costimulatory molecule or apoptosis induction. In this figure seven representative cases are represented. Densitometric analysis of (B) p-JNK(p54)/β-actin (C) p-JNK(p46)/β-actin and (C) p-p38/β-actin levels in the 12 CLL samples analyzed. The graphs represent the median values for each group which determined as the ratio of the optical density (OD) of p-protein and β-actin using the ImageJ software (National Institutes of Health, Bethesda, MD, USA; https://doi.org/imagej.nih.gov/ij/, 1997–2012). IIM, imiquimod; M: mutated; UM: unmutated; non #4 (4_34), cases expressing the IGHV4-34 gene in non-stereotyped rearrangements; #1, stereotyped subset #1; +, positive control (CLL cells treated for 1 h with CpG).Back to article page